Followers

July 02, 2024

Cartesian's immune disorder therapy meets main goal in mid-stage study

The therapy known as descartes-08 is a chimeric antigen receptor T-cell therapy, or CAR-T cell therapy, to treat patients with myasthenia gravis an autoimmune disorder that causes disabling muscle weakness and fatigue.

from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/HpiNPV2

No comments:

Post a Comment